Product References
ASGR1 promotes liver injury in sepsis by modulating monocyte-to-macrophage differentiation via NF-κB/ATF5 pathway.
Life sciences
Shi R,Wang J,Zhang Z,Leng Y,Chen AF
Wed Feb 15 00:00:00 UTC 2023
ASGR1 promotes liver injury in sepsis by modulating monocyte-to-macrophage differentiation via NF-κB/ATF5 pathway.
Life sciences
Shi R,Wang J,Zhang Z,Leng Y,Chen AF
Wed Feb 15 00:00:00 UTC 2023
ASGR1 promotes liver injury in sepsis by modulating monocyte-to-macrophage differentiation via NF-κB/ATF5 pathway.
Life sciences
Shi R,Wang J,Zhang Z,Leng Y,Chen AF
Wed Feb 15 00:00:00 UTC 2023
ASGR1 promotes liver injury in sepsis by modulating monocyte-to-macrophage differentiation via NF-κB/ATF5 pathway.
Life sciences
Shi R,Wang J,Zhang Z,Leng Y,Chen AF
Wed Feb 15 00:00:00 UTC 2023
ASGR1 promotes liver injury in sepsis by modulating monocyte-to-macrophage differentiation via NF-κB/ATF5 pathway.
Life sciences
Shi R,Wang J,Zhang Z,Leng Y,Chen AF
Wed Feb 15 00:00:00 UTC 2023
ASGR1 promotes liver injury in sepsis by modulating monocyte-to-macrophage differentiation via NF-κB/ATF5 pathway.
Life sciences
Shi R,Wang J,Zhang Z,Leng Y,Chen AF
Wed Feb 15 00:00:00 UTC 2023
Liver cancer cells as the model for developing liver-targeted RNAi therapeutics.
Biochemical and biophysical research communications
Hou B,Qin L,Huang L
Sun Feb 12 00:00:00 UTC 2023
Decellularized Liver Nanofibers Enhance and Stabilize the Long-Term Functions of Primary Human Hepatocytes In Vitro.
Advanced healthcare materials
Liu JS,Madruga LYC,Yuan Y,Kipper MJ,Khetani SR
Sat Jul 01 00:00:00 UTC 2023
Inhibition of ASGR1 decreases lipid levels by promoting cholesterol excretion.
Nature
Wang JQ,Li LL,Hu A,Deng G,Wei J,Li YF,Liu YB,Lu XY,Qiu ZP,Shi XJ,Zhao X,Luo J,Song BL
Mon Aug 01 00:00:00 UTC 2022
ASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma Growth.
Cancer research
Ma WK,Voss DM,Scharner J,Costa ASH,Lin KT,Jeon HY,Wilkinson JE,Jackson M,Rigo F,Bennett CF,Krainer AR
Tue Mar 01 00:00:00 UTC 2022
Dual targeted delivery of statins and nucleic acids by chitosan-based nanoparticles for enhanced antiatherosclerotic efficacy.
Biomaterials
Jiang T,Xu L,Zhao M,Kong F,Lu X,Tang C,Yin C
Sat Jan 01 00:00:00 UTC 2022
Modeling nonalcoholic fatty liver disease on a liver lobule chip with dual blood supply.
Acta biomaterialia
Du K,Li S,Li C,Li P,Miao C,Luo T,Qiu B,Ding W
Fri Oct 15 00:00:00 UTC 2021
Neuraminidases 1 and 3 Trigger Atherosclerosis by Desialylating Low-Density Lipoproteins and Increasing Their Uptake by Macrophages.
Journal of the American Heart Association
Demina EP,Smutova V,Pan X,Fougerat A,Guo T,Zou C,Chakraberty R,Snarr BD,Shiao TC,Roy R,Orekhov AN,Miyagi T,Laffargue M,Sheppard DC,Cairo CW,Pshezhetsky AV
Tue Feb 16 00:00:00 UTC 2021
Neuraminidases 1 and 3 Trigger Atherosclerosis by Desialylating Low-Density Lipoproteins and Increasing Their Uptake by Macrophages.
Journal of the American Heart Association
Demina EP,Smutova V,Pan X,Fougerat A,Guo T,Zou C,Chakraberty R,Snarr BD,Shiao TC,Roy R,Orekhov AN,Miyagi T,Laffargue M,Sheppard DC,Cairo CW,Pshezhetsky AV
Tue Feb 16 00:00:00 UTC 2021
Regulated control of gene therapies by drug-induced splicing.
Nature
Monteys AM,Hundley AA,Ranum PT,Tecedor L,Muehlmatt A,Lim E,Lukashev D,Sivasankaran R,Davidson BL
Sun Aug 01 00:00:00 UTC 2021
Phosphatidylserine-deficient small extracellular vesicle is a major somatic cell-derived sEV subpopulation in blood.
iScience
Matsumoto A,Takahashi Y,Ogata K,Kitamura S,Nakagawa N,Yamamoto A,Ishihama Y,Takakura Y
Fri Aug 20 00:00:00 UTC 2021
A Potent Branched-Tail Lipid Nanoparticle Enables Multiplexed mRNA Delivery and Gene Editing In Vivo.
Nano letters
Hajj KA,Melamed JR,Chaudhary N,Lamson NG,Ball RL,Yerneni SS,Whitehead KA
Wed Jul 08 00:00:00 UTC 2020
Enhanced Potency of GalNAc-Conjugated Antisense Oligonucleotides in Hepatocellular Cancer Models.
Molecular therapy : the journal of the American Society of Gene Therapy
Kim Y,Jo M,Schmidt J,Luo X,Prakash TP,Zhou T,Klein S,Xiao X,Post N,Yin Z,MacLeod AR
Wed Sep 04 00:00:00 UTC 2019
Enhanced Potency of GalNAc-Conjugated Antisense Oligonucleotides in Hepatocellular Cancer Models.
Molecular therapy : the journal of the American Society of Gene Therapy
Kim Y,Jo M,Schmidt J,Luo X,Prakash TP,Zhou T,Klein S,Xiao X,Post N,Yin Z,MacLeod AR
Wed Sep 04 00:00:00 UTC 2019
Delivery of GalNAc-Conjugated Splice-Switching ASOs to Non-hepatic Cells through Ectopic Expression of Asialoglycoprotein Receptor.
Molecular therapy. Nucleic acids
Scharner J,Qi S,Rigo F,Bennett CF,Krainer AR
Fri Jun 07 00:00:00 UTC 2019
Delivery of GalNAc-Conjugated Splice-Switching ASOs to Non-hepatic Cells through Ectopic Expression of Asialoglycoprotein Receptor.
Molecular therapy. Nucleic acids
Scharner J,Qi S,Rigo F,Bennett CF,Krainer AR
Fri Jun 07 00:00:00 UTC 2019
Characterization of Cellular Sources and Circulating Levels of Extracellular Vesicles in a Dietary Murine Model of Nonalcoholic Steatohepatitis.
Hepatology communications
Li J,Liu H,Mauer AS,Lucien F,Raiter A,Bandla H,Mounajjed T,Yin Z,Glaser KJ,Yin M,Malhi H
Sun Sep 01 00:00:00 UTC 2019
The FUT2 secretor variant p.Trp154Ter influences serum vitamin B12 concentration via holo-haptocorrin, but not holo-transcobalamin, and is associated with haptocorrin glycosylation.
Human molecular genetics
Velkova A,Diaz JEL,Pangilinan F,Molloy AM,Mills JL,Shane B,Sanchez E,Cunningham C,McNulty H,Cropp CD,Bailey-Wilson JE,Wilson AF,Brody LC
Fri Dec 15 00:00:00 UTC 2017
The FUT2 secretor variant p.Trp154Ter influences serum vitamin B12 concentration via holo-haptocorrin, but not holo-transcobalamin, and is associated with haptocorrin glycosylation.
Human molecular genetics
Velkova A,Diaz JEL,Pangilinan F,Molloy AM,Mills JL,Shane B,Sanchez E,Cunningham C,McNulty H,Cropp CD,Bailey-Wilson JE,Wilson AF,Brody LC
Fri Dec 15 00:00:00 UTC 2017